| Literature DB >> 33904776 |
Giuseppe Petralia1, Dow-Mu Koh1, Raj Attariwala1, Joseph J Busch1, Ros Eeles1, David Karow1, Gladys G Lo1, Christina Messiou1, Evis Sala1, Hebert A Vargas1, Fabio Zugni1, Anwar R Padhani1.
Abstract
Acknowledging the increasing number of studies describing the use of whole-body MRI for cancer screening, and the increasing number of examinations being performed in patients with known cancers, an international multidisciplinary expert panel of radiologists and a geneticist with subject-specific expertise formulated technical acquisition standards, interpretation criteria, and limitations of whole-body MRI for cancer screening in individuals at higher risk, including those with cancer predisposition syndromes. The Oncologically Relevant Findings Reporting and Data System (ONCO-RADS) proposes a standard protocol for individuals at higher risk, including those with cancer predisposition syndromes. ONCO-RADS emphasizes structured reporting and five assessment categories for the classification of whole-body MRI findings. The ONCO-RADS guidelines are designed to promote standardization and limit variations in the acquisition, interpretation, and reporting of whole-body MRI scans for cancer screening. Published under a CC BY 4.0 license Online supplemental material is available for this article.Entities:
Mesh:
Year: 2021 PMID: 33904776 DOI: 10.1148/radiol.2021201740
Source DB: PubMed Journal: Radiology ISSN: 0033-8419 Impact factor: 11.105